Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the National Cancer Institute

• Publication date

  2002-08-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JNCI/94.16.1197PMID 12189222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic markers of breast cancer: enhanced choline metabolism and reduced choline-ether-phospholipid synthesis.

  2002cited by this paper
• Evaluation of breast lesions by power Doppler sonography

  2001cited by this paper
• Magnification Views of Mammography Decrease Biopsy Rates

  2001cited by this paper
• Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer

  2001cited by this paper
• Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.

  2001cited by this paper
• Differential routing of choline in implanted breast cancer and normal organs

  2001cited by this paper
• The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy

  2001cited by this paper
• MR imaging of the breast for the detection, diagnosis, and staging of breast cancer.

  2001cited by this paper
• Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

  2001cited by this paper
• Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results.

  2001cited by this paper
• Classification of in vivo 1H MR spectra from breast tissue using artificial neural networks.

  2001cited by this paper
• Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

  2001cited by this paper
• Yield of mammography in selected patients age ≤ 30 years

  2001cited by this paper
• Tubular adenomas of the breast: imaging findings with histologic correlation.

  2000cited by this paper
• Breast imaging technology: Imaging biochemistry - applications to breast cancer

  2000cited by this paper
• Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography.

  2000cited by this paper
• The evaluation of false negative mammography from malignant and benign breast lesions.

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• Proton magnetic resonance spectroscopy

  1999cited by this paper
• Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells.

  1999cited by this paper
• Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging.

  1999cited by this paper
• Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy

  1999cited by this paper
• Human breast lesions: characterization with proton MR spectroscopy.

  1998cited by this paper
• Proton Magnetic Resonance Spectroscopy: An Emerging Technology in Pediatric Neurology Research

  1998cited by this paper
• In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil

  1998cited by this paper
• Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.

  1997cited by this paper
• Study of the metabolism of choline and phosphatidylcholine in tumors in vivo using phosphonium‐choline

  1997cited by this paper
• Mapping pathophysiological features of breast tumors by MRI at high spatial resolution

  1997cited by this paper
• Recent trends in breast cancer mortality among white and black US women.

  1997cited by this paper
• Effect of age, breast density, and family history on the sensitivity of first screening mammography.

  1996cited by this paper
• Recent trends in U.S. breast cancer incidence, survival, and mortality rates.

  1996cited by this paper
• Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells.

  1996cited by this paper
• Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy

  1996cited by this paper
• Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study.

  1995cited by this paper
• NMR in physiology and biomedicine

  1994cited by this paper
• [In vitro NMR spectroscopy of healthy, pathologically changed and carcinomatous breast tissue samples correlated with histological findings].

  1994cited by this paper
• 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non‐involved breast tissue

  1994cited by this paper
• Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy.

  1994cited by this paper
• IN-VITRO NMR-SPECTROSCOPY OF HEALTHY - MASTOPATHICALLY MODIFIED AND CARCINOMATOUS BREAST-TISSUE SAMPLES CORRELATED WITH HISTOLOGICAL-FINDINGS

  1994cited by this paper
• Breast Cancer: Spectroscopy and Imaging of Cells and Tumors

  1994cited by this paper
• Incidence of breast cancer.

  1993cited by this paper
• Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study.

  1993cited by this paper
• Glycerophosphocholine and phosphocholine are the major choline metabolites in rat milk.

  1993cited by this paper
• In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Therapeutic response of breast carcinoma monitored by 31P MRS in situ

  1989cited by this paper
• Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T.

  1988cited by this paper
• Breast tumors: evaluation with P-31 MR spectroscopy.

  1986cited by this paper

• Aromatase Inhibitor Therapy Is Associated with Distinct Plasma Lipidomic Profiles in Postmenopausal Breast Cancer Patients.

  2026cites this paper
• Chemical exchange saturation transfer imaging and diffusion weighted imaging for colon 26 tumor bearing mice

  2025cites this paper
• The Contribution of MR Spectroscopy to the Diagnosis of BIRADS 4 and 5 Breast Lesions

  2024cites this paper
• Correlation between choline kinase alpha expression and 11C-choline accumulation in breast cancer using positron emission tomography/computed tomography: a retrospective study

  2023cites this paper
• Chicken muscle antibody array reveals the regulations of LDHA on myoblast differentiation through energy metabolism.

  2023cites this paper
• Probing lipids relaxation times in breast cancer using magnetic resonance spectroscopic fingerprinting

  2023cites this paper
• Mapping of exogenous choline uptake and metabolism in rat glioblastoma using deuterium metabolic imaging (DMI)

  2023cites this paper
• Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

  2022cites this paper
• Diagnostic value of MR spectroscopy in suspicious breast lesions

  2022cites this paper
• Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells

  2022cites this paper
• History of Research on Phospholipid Metabolism and Applications to the Detection, Diagnosis, and Treatment of Cancer

  2022cites this paper
• Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism

  2022cites this paper
• MR spectroscopy in breast cancer metabolomics

  2021cites this paper
• Imaging in Breast Cancer: Use of Magnetic Resonance Spectroscopy

  2020cites this paper
• Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.

  2019cites this paper
• Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis

  2019cites this paper
• Role of magnetic resonance spectroscopy in evaluation of breast masses

  2019cites this paper
• Spektroskopija dojke magnetnom rezonancijom

  2019cites this paper
• In vivo MR spectroscopy for breast cancer diagnosis

  2019cites this paper
• Changes in total choline concentration in the breast of healthy fertile young women in relation to menstrual cycle or use of oral contraceptives: a 3-T 1H-MRS study

  2018cites this paper
• Application of in vivo MR methods in the study of breast cancer metabolism

  2018cites this paper
• MRI of the breast : novel metabolic imaging technique for cancer detection ?

  2018cites this paper
• A CROSS-SECTIONAL RESEARCH TO IDENTIFY MRS (MAGNETIC RESONANCE SPECTROSCOPY) CORRECTNESS IN THE BREAST LESIONS OF CANCER

  2018cites this paper
• Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas

  2018cites this paper
• Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo 1H MR spectroscopy.

  2018cites this paper
• Use Case III: Imaging Biomarkers in Breast Tumours. Development and Clinical Integration

  2017cites this paper
• Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA

  2017cites this paper
• Breast Tissue Metabolism by Magnetic Resonance Spectroscopy

  2017cites this paper
• Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women

  2016cites this paper
• Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.

  2016cites this paper
• Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.

  2016cites this paper
• Application of Single Voxel 1H Magnetic Resonance Spectroscopy in Hepatic Benign and Malignant Lesions

  2016cites this paper
• Noninvasive strategies for breast cancer early detection.

  2016cites this paper
• Bone Marrow Lipid Profiles from Peripheral Skeleton as Potential Biomarkers for Osteoporosis: A 1H-MR Spectroscopy Study.

  2016cites this paper
• Non‐invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism

  2016cites this paper
• In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer

  2016cites this paper
• Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion

  2016cites this paper
• Comprehensive quantitative lipidomic approach to investigate serum phospholipid alterations in breast cancer

  2016cites this paper
• Clinical Breast MR Using MRS or DWI: Who Is the Winner?

  2016cites this paper
• Proton and phosphorus magnetic resonance spectroscopy of the healthy human breast at 7 T

  2016cites this paper
• Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy

  2016cites this paper
• Targeting Phospholipid Metabolism in Cancer

  2016cites this paper
• Multiparametric MR Imaging of Breast Cancer.

  2016cites this paper
• The Sensitivity of Phosphocholine 13C Chemical Shifts to pH

  2015cites this paper
• A New Approach in DCE MRI Data Analysis for Differentiating Benign and Malignant Breast Lesions

  2015cites this paper
• Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

  2015cites this paper
• Metabolomic changes during cellular transformation monitored by metabolite–metabolite correlation analysis and correlated with gene expression

  2015cites this paper
• Proof-of-the-Concept Study on Mathematically Optimized Magnetic Resonance Spectroscopy for Breast Cancer Diagnostics

  2015cites this paper
• Towards Early Diagnosis and Assessment of Cancer : Role of MRI and in-vivo MR Spectroscopy ( MRS )

  2015cites this paper
• Imaging surveillance programs for women at high breast cancer risk in Europe: Are women from ethnic minority groups adequately included? (Review).

  2015cites this paper
• Quantitative Analysis of Brain Metabolite Spectrum Depending on the Concentration of the Contrast Media in Phantom

  2015cites this paper
• Expression profiling of choline and ethanolamine kinases in MCF7, HCT116 and HepG2 cells, and the transcriptional regulation by epigenetic modification.

  2015cites this paper
• The role of conventional and functional MRI in diagnosis of breast masses

  2015cites this paper
• Assessment of breast mass: Utility of diffusion-weighted MR imaging and MR spectroscopy (h 1 MRS) imaging

  2015cites this paper
• Strategic Steps for Advanced Molecular Imaging with Magnetic Resonance-Based Diagnostic Modalities

  2015cites this paper
• CTP:phosphocholine cytidylyltransferase: Function, regulation, and structure of an amphitropic enzyme required for membrane biogenesis.

  2015cites this paper
• Magnetic Resonance Spectroscopy and Imaging in Breast Cancer Prognosis and Diagnosis

  2015cites this paper
• 3.26 – Interdisciplinarity of MR and Future Perspectives with a Focus on Screening

  2014cites this paper
• Insights into the Role of Choline Kinase in Endochondral Bone Formation and Human Osteoblasts Function

  2014cites this paper
• Choline transporter-like proteins CTLs/SLC44 family as a novel molecular target for cancer therapy.

  2014cites this paper
• Overview of Functional MR, CT, and US Imaging Techniques in Clinical Use

  2014cites this paper
• Current Opportunities and Challenges of Magnetic Resonance Spectroscopy, Positron Emission Tomography, and Mass Spectrometry Imaging for Mapping Cancer Metabolism In Vivo

  2014cites this paper
• Research and progress in magnetic resonance imaging of triple-negative breast cancer.

  2014cites this paper
• Phosphatidylcholine metabolism and choline kinase in human osteoblasts.

  2014cites this paper
• The Role of in vivo Proton Magnetic Resonance Spectroscopy (MRS) in the Evaluation of Breast and Prostate Cancers

  2014cites this paper
• The Efficiency of Diffusion Weighted MRI and MR Spectroscopy On Breast MR Imaging.

  2014cites this paper
• 3.24 – Basic Science Input into Clinical MR Modalities

  2014cites this paper
• 3.19 – MRS of the Breast

  2014cites this paper
• Choline metabolism and choline kinase gene expression in human breast cancer

  2014cites this paper
• Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells – a preclinical MR study in mice

  2014cites this paper
• Padé optimization of noise-corrupted magnetic resonance spectroscopic time signals from fibroadenoma of the breast

  2014cites this paper
• Magnetic resonance imaging in breast cancer: A literature review and future perspectives.

  2014cites this paper
• The contribution of diffusion tensor imaging and magnetic resonance spectroscopy for the differentiation of breast lesions at 3T

  2014cites this paper
• Direct Inhibition of Choline Kinase by a Near-Infrared Fluorescent Carbocyanine

  2014cites this paper
• Magnetic Resonance in the Detection of Breast Cancers of Different Histological Types

  2013cites this paper
• Breast lesions: diagnosis by using proton MR spectroscopy at 1.5 and 3.0 T--systematic review and meta-analysis.

  2013cites this paper
• Investigation of positron emission tomography for pharmacological assessment of epidermal growth factor receptor-directed therapies

  2013cites this paper
• Focus on Dynamic Contrast-enhanced in Breast Cancer

  2013cites this paper
• Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.

  2013cites this paper
• Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing breast tumors

  2013cites this paper
• Magnetic resonance spectroscopy of the breast: current status.

  2013cites this paper
• Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.

  2013cites this paper
• The role of phosphatidylcholine and choline metabolites to cell proliferation and survival

  2013cites this paper
• Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI)

  2013cites this paper
• Molecular Imaging Techniques in Clinical Practice of Tumors

  2013cites this paper
• Ex vivo 1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients.

  2013cites this paper
• Combining DCE-MRI and 1H-MRS spectroscopy by distribution free approach results in a high performance marker: Initial study in breast patients

  2013cites this paper
• Investigating the introduction of spectroscopy and diffusion-weighted imaging (DWI) sequences to increase the specificity of breast magnetic resonance imaging (MRI)

  2013cites this paper
• Resolution enhancement as a key step towards clinical implementation of Padé-optimized magnetic resonance spectroscopy for diagnostic oncology

  2013cites this paper
• An Implantable RF Solenoid for Magnetic Resonance Microscopy and Microspectroscopy

  2012cites this paper
• Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer

  2012cites this paper
• CEST-imaging: A new contrast in MR-mammography by means of chemical exchange saturation transfer.

  2012influential citation
• Role of apparent diffusion coefficient values for the differentiation of viable and necrotic areas of breast cancer and its potential utility to guide voxel positioning for MRS in the absence of dynamic contrast-enhanced MRI data.

  2012cites this paper
• Utilidad de la resonancia magnética testicular con espectroscopía en el análisis cuantitativo de la infertilidad

  2012cites this paper
• Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: An MRI and in vivo proton MRS study

  2012cites this paper
• Noninvasive imaging identifies new roles for cyclooxygenase‐2 in choline and lipid metabolism of human breast cancer cells

  2012cites this paper
• In vivo magnetic resonance spectroscopy of cancer

  2012cites this paper
• Regulation of lipid metabolism in breast cancer provides diagnostic and therapeutic opportunities

  2012cites this paper
• Role of proton MR spectroscopy in the high field magnet (3T) in diagnosis of indeterminate breast masses (BIRDS 3 & 4)

  2012cites this paper
• Stable isotope-resolved metabolomics and applications for drug development.

  2012cites this paper